Go to deals
Private Equity | Healthcare

DCN Dx has received a growth equity investment from Martis Capital

DCN Dx, a leading provider of contract development services, has received a growth equity investment from Martis Capital.

DCN Dx offers contract development services for clients seeking to explore, develop and commercialize rapid diagnostic tests related to lateral flow assay. DCN Dx supports an array of customers including global diagnostics manufacturers, nonprofits seeking tests for low-resource settings and start-ups launching diagnostic-based products. Over the past 15 years, DCN Dx has successfully developed more than 100 rapid diagnostic tests for its customers.

Martis Capital is a private equity firm which manages more than US$1.2 billion of equity and is focused exclusively on investing in middle-market growth companies in the healthcare industry.

One of Oaklins’ teams in the USA, together with Pegasus Capital, served as a financial advisor to DCN Dx, in connection with a growth equity investment from Martis Capital.

Service
M&A sell-side
Parties

Talk to the deal team

 Bradford A. Adams

Bradford A. Adams

Managing Director

Boston, United States
Oaklins TM Capital
 Michael S. Goldman

Michael S. Goldman

Managing Director

New York, United States
Oaklins TM Capital
 James  McLaren

James McLaren

Managing Director

New York, United States
Oaklins TM Capital

Related deals

Zoofy has raised growth capital for its expansion into Germany
Private Equity | Construction & Engineering Services | TMT

Zoofy has raised growth capital for its expansion into Germany

Zoofy, an Amsterdam-based platform connecting professional handymen with consumers and businesses, has raised growth capital from a private investor for its expansion into Germany. The company expects to launch its German platform in the second quarter of this year.

Learn more
Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital
Private Equity | Healthcare

Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital

Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.

Learn more
Inside Pensions has been acquired by ZEDRA Group
Private Equity | Business Support Services

Inside Pensions has been acquired by ZEDRA Group

The owners of Inside Pension Ltd. have sold the business to ZEDRA Group.

Learn more